Abbott Appeals $1.9B Hit In Patent Suit Over Humira

Law360, New York (December 22, 2009, 12:05 PM EST) -- Abbott Laboratories is appealing a $1.85 billion judgment imposed against it after a jury found that the drugmaker's arthritis treatment Humira infringed a patent asserted by Johnson & Johnson unit Centocor Ortho Biotech Inc.

Abbott filed a notice of appeal Monday in the U.S. District Court for the Eastern District of Texas, taking the case to the U.S. Court of Appeals for the Federal Circuit.

Judge T. John Ward entered final judgment in the case on Friday, adding interest of nearly $176 million on the record...
To view the full article, register now.